UCI-LC0019
UCI-LC0019 is a mutant p53 reactivator. UCI-LC0019 binds to mutant p53, induces wild-type-like conformational change, restores sequence-specific DNA binding activity, activates p53-dependent transcription programs, and does not act via thiol reactivity or glutathione depletion. UCI-LC0019 inhibits proliferation and induces apoptosis in cancer cells harboring mutant p53, with no significant effect on p53null or wild-type p53 tumors cells. UCI-LC0019 exhibits anti-tumor activity in xenograft mouse models carrying p53R175H mutant tumors. UCI-LC0019 can be used for the research of cancer, such as ovarian cancer.
For research use only. We do not sell to patients.
- Purity: 98.63%
- CAS No.: 1372406-51-3
- Formula: C17H14N2O2
- Molecular Weight:278.31
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HCT-116 | IC50 |
0.58 μM
Compound: A9
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 27017265] |
UCI-LC0019 potently inhibits proliferation of p53G245S-expressing Saos-2 cells (IC50 = 16.5 μM) and p53R175H-expressing TOV112D cells (IC50 = 15.2 μM) with reduced activity against p53null Saos-2 cells (IC50 = 24.1 μM)[1].
UCI-LC0019 (0-30 μM; 3-72 h) rapidly reduces proliferation and induces apoptosis in p53R175H-expressing TOV112D cells[1].
UCI-LC0019 (25-30 μM; 3 days) inhibits proliferation of p53R175H-expressing TOV112D cells via a mechanism independent of thiol reactivity, as co-treatment with 5 mM NAC (HY-B0215) does not reverse its antiproliferative effects[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:p53R175H-expressing TOV112D cells
-
Concentration:30 μM
-
Incubation Time:3, 12, 24 h
-
Result:Induced rapid cell death time-dependently.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice with p53R175H-expressing TOV112D Xenografts[1]
-
Dosage:10 mg/kg
-
Administration:i.p.; daily for 10 days
-
Result:Reduced tumor volume.
Increased GSH levels.
Did not result in weight loss or any obvious toxic effects.
Chemical Information
-
CAS No. 1372406-51-3
-
Appearance Solid
-
Molecular Weight 278.31
-
Formula C17H14N2O2
-
Color Light yellow to yellow
-
SMILES
COC1=CC=CC(/C=C/C(C2=NC3=CC=CC=C3N2)=O)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)